SAVOCEL
Aventis Pharma S.a.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78103301 |
| Registration Number | 3019546 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Cancellation Code | 2 |
| Domestic Representative | FROSS ZELNICK LEHRMAN & ZISSU, P.C. |
| Attorney Name | SUSAN UPTON DOUGLASS |
| Law Office Assigned | M10 |
| Employee Name | BLOHM, LINDA E |
Timeline
| 2002-01-17 | Application Filed |
| 2002-12-17 | Published for Opposition |
| 2005-11-29 | Location: PUBLICATION AND ISSUE SECTION |
| 2005-11-29 | Trademark Registered |
| 2012-07-06 | Cancelled |
| 2012-07-06 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  AVENTIS PHARMA S.A. |
| Address | 20, Avenue Raymond Aron Antony Cedex FR 92160 |
| Legal Entity Type | Corporation |
| Legal Entity State | FR |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the treatment of cardiovascular disorders |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| ASSIGNED TO EXAMINER | 2002-05-09 | 1 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION E-MAILED | 2002-06-11 | 2 GNRT F:First Action |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2002-07-11 | 3 CRFA I:Incoming Correspondence |
| LETTER OF SUSPENSION E-MAILED | 2002-08-15 | 4 GNSL S: |
| PAPER RECEIVED | 2002-09-12 | 5 MAIL I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2002-09-12 | 6 CRFA I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2002-10-04 | 7 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2002-10-10 | 8 CNSA P: |
| NOTICE OF PUBLICATION | 2002-11-27 | 9 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2002-12-17 | 10 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2003-03-11 | 11 NOAM O:Outgoing Correspondence |
| TEAS EXTENSION RECEIVED | 2003-08-25 | 12 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2003-08-25 | 13 EXT1 S: |
| EXTENSION 1 GRANTED | 2003-09-01 | 14 EX1G S: |
| TEAS EXTENSION RECEIVED | 2004-01-14 | 15 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2004-01-14 | 16 EXT2 S: |
| EXTENSION 2 GRANTED | 2004-02-05 | 17 EX2G S: |
| CASE FILE IN TICRS | 2004-08-10 | 18 CFIT O:Outgoing Correspondence |
| TEAS EXTENSION RECEIVED | 2004-09-09 | 19 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2004-09-09 | 20 EXT3 S: |
| EXTENSION 3 GRANTED | 2004-09-17 | 21 EX3G S: |
| TEAS EXTENSION RECEIVED | 2004-12-14 | 22 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2004-12-14 | 23 EXT4 S: |
| EXTENSION 4 GRANTED | 2004-12-22 | 24 EX4G S: |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2005-08-16 | 25 TCCA I:Incoming Correspondence |
| PAPER RECEIVED | 2005-08-19 | 26 MAIL I:Incoming Correspondence |
| NOTICE OF ALLOWANCE CANCELLED | 2005-08-19 | 27 IUCN S: |
| 1(B) BASIS DELETED; PROCEED TO REGISTRATION | 2005-09-02 | 28 DP1B I:Incoming Correspondence |
| PAPER RECEIVED | 2005-09-12 | 29 MAIL I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2005-09-23 | 30 CHAN I:Incoming Correspondence |
| REGISTERED-PRINCIPAL REGISTER | 2005-11-29 | 31 R.PR A:Allowance for Publication |
| CANCELLED SEC. 8 (6-YR) | 2012-07-06 | 32 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 SAVOCEL 78779639 not registered Dead/Abandoned |
Aventis Pharma S.A. 2005-12-22 |
 SAVOCEL 78103301 3019546 Dead/Cancelled |
AVENTIS PHARMA S.A. 2002-01-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 